<!-----------------------------------------------------------------------------------
--
-- Management Team
--
------------------------------------------------------------------------------------->
<div class="container medlab_panel_container">
    <div class="row">
        <div class="col-md-12 col-sm-12 col-xs-12">
            <!--
            -- Management Team
            -->
            <div class="panel panel-primary medlab_panel">
                <div class="panel-heading medlab_panel_title">
                    EXECUTIVE TEAM
                </div>
                <div class="panel-body medlab_panel_content">
                    <p style="text-align: left;" align="center">
                        <strong>
                            <img src="/img/about/sean.jpg" alt="" height="150" />
                            &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;Sean Hall
                        </strong>
                        CEO/MD
                    </p>
                    <p>
                        Sean was one of the founders of FIT-BioCeuticals LTD (www.fit-bioceuticals.com.au) and through Sean's management and guidance, BioCeuticals (leading brand) expanded into a leadership role in the Australian Health Care community.&nbsp; Supported by novel research, FIT-BioCeuticals developed innovative products that were both patentable and coveted on the world stage.
                    </p>
                    <p>
                        Due to the market positioning and leadership of the BioCeuticals range, Sean sold his interest in FIT-BioCeuticals LTD in July 2012 at a premium rate (14.5 x P.E &amp; 10 x EBITDA). &nbsp;Sean started Medlab in August 2012, which focuses on research and development for new drugs in the area of biologics.
                    </p>
                    <p>
                        Sean Hall has over 20 years experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the USA.&nbsp; Sean's focus on leadership and innovation has led to the authoring of multiple patents, written peer reviewed articles and lectures at scientific conferences. His passion is in research and leading research teams into novel areas and strong commercialization opportunities.
                    </p>
                    <p>
                        Sean is the current CEO of Medlab Australia, specialising in early phase drug development in Biologics and bacteria identification. He is also a Board Member of the International Probiotics Association (IPA). Sean is the 2012 Finalist Australian Growth Company Awards, CEO Exit of the Year for his trade sale to Blackmores.
                    </p>

                    <hr>

                    <p>
                        &nbsp;&nbsp;
                        <strong>
                            <img src="/img/about/alan_1.png" alt="" height="150" />
                            <strong>
                                &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;
                            </strong>
                        </strong>
                        <strong>
                            Alan Dworkin&nbsp;
                        </strong>
                        Chief Financial Officer, Company Secretary
                    </p>
                    <p>
                        Alan Dworkin is a Chartered Accountant with over 18 years experience in tax, retail, resources and nutraceutical sectors.
                    </p>
                    <p>
                        Alan is employed by Medlab as Chief Financial Officer and Company Secretary. Prior to this, Alan was employed as the Chief Financial Officer and Company Secretary of FIT-Bioceuticals Limited for over 6 years. Alan has also had experience in ASX listed companies within the resources sector, most recently as Company Secretary of Uramet Minerals Limited.
                    </p>
                    <p>
                        Alan is a member of the Institute of Chartered Accountants in Australia, the Governance Institute in Australia and the Australian Institute of Company Directors.
                    </p>

                    <hr>

                    <p>
                        &nbsp;
                        <strong>
                            <img src="/img/about/luis.jpg" alt="" />
                            <strong>
                                &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;
                            </strong>
                            Luis Vitetta
                        </strong>
                        Director of Medical Research
                    </p>
                    <p>
                        Professor Luis Vitetta brings to the Medlab executive team a wide range of expertise in probiotics and nutraceutical mechanistic understanding.&nbsp; This insight emanates from his focused clinical and scientific research that assists Medlab&rsquo;s commercialisation portfolio of biologics, thereby value adding a further dimension to Medlab&rsquo;s intellectual property paradigm.
                    </p>
                    <p>
                        Furthermore, many years of educating clinicians, pharmacists,&nbsp;undergraduate and postgraduate students, Luis is placed in a strong position to advance Medlab&rsquo;s clinical research activities and drug innovation projects to the clinical practitioner community.
                    </p>

                    <hr>
                    <p>
                        <strong>
                            <img src="/img/about/david.jpg" alt="David Rutolo" />
                            <strong>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong>
                            Dr David Rutolo&nbsp;
                        </strong>
                        Director of Science
                    </p>
                    <p>
                        David has 35 years experience in research, product development, manufacturing, and technical marketing support in the pharmaceutical and nutritional industry. He earned his PhD in organic chemistry at the University of California at Irvine and a JD from Western State University, College of Law. In addition, he holds a Certificate of Completion in FDA Law from the University of Southern California
                    </p>
                    <p>
                        <span>
                            David is a major contributor to the American functional food and high-profile bottled juice market segments, and he continues to develop health care products specifically designed for the international marketplace. Through a number of private development associations, he consults and formulates nutritional products for Asia, Europe South America and Australia.
                        </span>
                    </p>
                    <p>
                        <span>
                            David was a Cofounder of Micelle Laboratories, Inc., where he served for over 20 years as Executive Vice-President and as a Board Member. The firm provides pharmaceutical and nutritional product development and manufacturing in an FDA drug-licensed facility. As a formulator, he developed unique functional foods, nutritional supplements, skin care formulations, veterinary formulas, and OTC products for a wide variety of domestic and foreign companies. At Micelle, he pioneered the development of micellization, a specialized and patented delivery system to enhance the absorption of fat-soluble substances, which is widely utilized by organizations in the production of nutritional and skin care preparations.
                        </span>
                    </p>
                    <p>
                        David manages and is a shareholder of InMed Technologies, Medlab&rsquo;s 60% owned US company.
                    </p>
                    <p>
                        <strong>
                            <br>
                        </strong>
                    </p>

                    <hr>

                    <p>
                        <strong>
                            <img src="/img/about/DSC_1068_1.jpeg" alt="Samantha Coulson" width="150" height="150" />
                            <strong>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong>
                            Dr&nbsp;Samantha Coulson,&nbsp;
                        </strong>
                        Senior Scientist, Head of Pharmacovigilance &amp; Regulatory affairs
                    </p>
                    <p>
                        Samantha holds a Bachelor degree in Health Science, Graduate Certificate in Research Commercialisation and a PhD in Medicine from the University of Queensland, School of Medicine based at the Princess Alexandra Hospital in Brisbane. Her PhD involved assessing the microbiota profile of patients with Osteoarthritis and the effect arthritic supplements, i.e. green-lipped mussel and glucosamine had on the gut bacterial profiles in relation to therapeutic effecacy. Samantha's current research at Medlab is focusing on the microbiome and its role in health and disease.
                    </p>
                </div>
            </div>
        </div>
    </div>
</div>